Clinical trials: Dermatosis Papulosa Nigra
Dermatosis Papulosa Nigra
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)
An open-label trial to explore the safety and efficacy of SM-020 gel 1.0% in subjects with Dermatosis Papulosa Nigra (DPN). Approximately 10 subjects will be enrolled with DPNs to apply SM-020 gel 1.0%.
- Trial name
- NCT06099080
- Testing
- SM-020 gel 1.0%
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- DermBiont, Inc.
Dermatosis Papulosa Nigra
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
Evaluate the safety and efficacy of hydrogen peroxide, A-101 Solution 40% for the treatment of DPN lesions on subjects with a Fitzpatrick Skin Type of 5 or 6.
- Trial name
- NCT03224598
- Testing
- A-101 Topical Solution 40%
- Where
- 2 sites in United States
- Volunteers
- 39 people
- Sponsor
- Aclaris Therapeutics, Inc.